- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil, Placebo, Etripamil Test Dose
- Drug
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,097 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 54
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Cerritos, California + 44 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 30
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Supraventricular Tachycardia (SVT)
- Interventions
- adenosine, diltiazem
- Drug
- Lead sponsor
- Anne E. Zepeski
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Interventions
- Etripamil, Placebo
- Drug
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 199 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Sacramento, California • Littleton, Colorado + 19 more
- Conditions
- Arrhythmias, Cardiac
- Interventions
- Not listed
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2035
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Supraventricular Tachycardia
- Interventions
- Digoxin, Propranolol
- Drug
- Lead sponsor
- University of British Columbia
- Other
- Eligibility
- Up to 4 Months
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2011
- U.S. locations
- 10
- States / cities
- Los Angeles, California • Orange, California • Kansas City, Missouri + 7 more
- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil NS 70 mg, Aptar Pharma Nasal Spray Bidose System
- Drug · Device
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 169 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 22
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Los Alamitos, California + 18 more
- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil NS
- Drug
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,116 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 61
- States / cities
- Gilbert, Arizona • Fremont, California • Stanford, California + 54 more
- Conditions
- Tachycardia, Atrioventricular Nodal Reentry
- Interventions
- Cardiac Invasive Electrophysiological Study
- Procedure
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 16 Years to 80 Years
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2021
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Syncope, Presyncope, Atrial Fibrillation, Supraventricular Tachycardia
- Interventions
- EKG Patch monitors (Zio and Carnation)
- Device
- Lead sponsor
- EvergreenHealth
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Kirkland, Washington
- Conditions
- Supraventricular Tachycardia (SVT)
- Interventions
- IV adenosine, IV diltiazem
- Drug
- Lead sponsor
- University of Iowa
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Interventions
- Not listed
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- Not listed
- Enrollment
- 354 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Congenital Disorders
- Interventions
- Not listed
- Lead sponsor
- Children's Healthcare of Atlanta
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1992 – 2008
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Syncope, Pre-syncope, Atrial Fibrillation, Supraventricular Tachycardia
- Interventions
- Standard Holter/Investigational patch
- Device
- Lead sponsor
- Seattle Institute for Cardiac Research
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 2
- States / cities
- Chicago, Illinois • Enumclaw, Washington
- Conditions
- Supraventricular Tachycardia
- Interventions
- Dexmedetomidine, Adenosine
- Drug
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 5 Years to 30 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Supraventricular Tachycardia
- Interventions
- Intracardiac echocardiography and 3D navigational system
- Device
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 8 Years to 21 Years
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- AtrioVentricular Nodal Reentrant Tachycardia, Supraventricular Tachycardia, Heart Disease
- Interventions
- Freezor Xtra Cryoablation Catheter
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 572 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Santa Monica, California • Stanford, California + 23 more
- Conditions
- Syncope, Presyncope, Palpitations, Atrial Fibrillation, Supraventricular Tachycardia
- Interventions
- Not listed
- Lead sponsor
- Bardy Diagnostics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 4
- States / cities
- Chicago, Illinois • Iowa City, Iowa • Charlotte, North Carolina + 1 more
- Conditions
- Supraventricular Tachycardia
- Interventions
- New Ablation Technique, Standard Ablation Technique
- Procedure
- Lead sponsor
- Jeffrey Moak
- Other
- Eligibility
- Up to 21 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 5
- States / cities
- Washington D.C., District of Columbia • Hollywood, Florida • Iowa City, Iowa + 2 more
- Conditions
- Atrial Fibrillation, Tachycardia, Supraventricular, Arrhythmia, Bradycardia
- Interventions
- Intervention Pacing Features
- Device
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Industry
- Eligibility
- Not listed
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2011
- U.S. locations
- 34
- States / cities
- Little Rock, Arkansas • Rancho Mirage, California • San Diego, California + 31 more
- Conditions
- Inappropriate Sinus Tachycardia
- Interventions
- electrophysiology study and radiofrequency ablation
- Procedure
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2020
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Syncope, Ventricular Tachycardia
- Interventions
- Early mobilization
- Other
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 2
- States / cities
- Portland, Oregon
- Conditions
- Ventricular Tachycardia, Ventricular Fibrillation, Atrial Fibrillation, Supraventricular Tachycardia
- Interventions
- Dual Chamber ICD, Single Chamber ICD
- Device
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 2
- States / cities
- Jacksonville, Florida • Rochester, Minnesota
- Conditions
- Paroxysmal Supraventricular Tachycardia
- Interventions
- Etripamil NS
- Drug
- Lead sponsor
- Milestone Pharmaceuticals Inc.
- Other
- Eligibility
- 6 Years to 17 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • Oak Lawn, Illinois • Cincinnati, Ohio + 3 more
- Conditions
- Atrial Flutter, Tachycardia, Supraventricular, Tachycardia, Atrial Ectopic, Tachycardia, Reciprocating, Tachycardia Atrial, Tachycardia, Atrioventricular Nodal Reentry, Tachycardia, Paroxysmal, Fetal Hydrops
- Interventions
- Prospective observational cohorts
- Other
- Lead sponsor
- Edgar Jaeggi
- Other
- Eligibility
- 16 Years to 50 Years · Female only
- Enrollment
- 330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2025
- U.S. locations
- 18
- States / cities
- Phoenix, Arizona • San Francisco, California • Denver, Colorado + 15 more